
Bristol Myers Squibb (NYSE: BMY)
Bristol Myers Squibb Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Bristol Myers Squibb Company Info
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
News & Analysis
What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
This High-Yield Pharma Stock Looks Like an Incredible Bargain
Biotech vs Pharma: What's the Difference?
Is Bristol Myers Squibb's High-Yielding Dividend Safe?
Beat the S&P 500 With This Cash-Gushing Dividend Stock
3 Deeply Discounted Dividend Stocks to Buy Today
Investing in Biotech Stocks in 2025
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Valuation
Podcast Episodes

3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year
These stocks skyrocketed following exciting announcements.
Carl Icahn Takes Aim at Bristol-Myers Squibb
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
In this Valentine's Day edition, Industry Focus explores cholesterol busters, heart surgery, and the latest in anticoagulants.
News! News! News! Here's What's Happened in Healthcare Last Week
From a big-time patent settlement between Merck & Co. and Bristol-Myers Squibb, to Johnson & Johnson's earnings, to Aetna and Humana's $37 billion merger bust, we dive into the details behind last week's biggest healthcare stories.
Earnings Transcripts
Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
BMY earnings call for the period ending December 31, 2024.
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2024.
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
BMY earnings call for the period ending June 30, 2024.
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
BMY earnings call for the period ending March 31, 2024.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.